Using advanced mobile health technologies and machine learning to improve HIV and drug abuse treatment
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
['FUNDING_OTHER'] · OHIO STATE UNIVERSITY · NIH-10886738
This study is exploring new mobile health tools and smart technology to better understand and treat pain in people living with HIV who use opioids, and it also aims to help train new researchers to improve care for these individuals in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-10886738 on ClinicalTrials.gov |
What this research studies
This research focuses on leveraging next-generation mobile health technologies and machine learning to enhance the understanding and treatment of HIV and substance abuse. It aims to develop innovative methods, such as digital phenotyping and invisible biosensing, to monitor and identify acute pain in individuals living with HIV who are also using opioids. By mentoring emerging researchers in this field, the project seeks to build capacity for future studies that can lead to improved health outcomes for affected populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals over 21 years old who are living with HIV and may also be using opioids.
Not a fit: Patients who are not living with HIV or who do not have issues related to substance abuse may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring and treatment strategies for individuals living with HIV and those struggling with substance abuse.
How similar studies have performed: Previous research has shown promising results using mobile health technologies and machine learning in similar contexts, indicating potential for success in this area.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOYER, EDWARD W — OHIO STATE UNIVERSITY
- Study coordinator: BOYER, EDWARD W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus